Literature DB >> 12084990

VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts.

Dietmar Abraham1, Shahrokh Taghavi, Patricia Riml, Patrick Paulus, Michael Hofmann, Claudia Baumann, Alfred Kocher, Walter Klepetko, Seyedhossein Aharinejad.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) is a potent endothelial cell growth and permeability factor, expressed in the lung. Overexpression of VEGF is associated with increased vascular permeability in the early stage of acute lung injury in mice. The role of various forms of VEGF in transplantation-induced lung injury is not well understood.
METHODS: VEGF mRNA and protein expression was measured in biopsies of preserved donor lung grafts as well as in control lung biopsies, using real-time reverse transcriptase-polymerase chain reaction and Western blot analysis. VEGF tissue expression was also evaluated by immunocytochemistry. Serum VEGF was measured in recipients after transplantation and in controls using ELISA.
RESULTS: Although VEGF-A and VEGF-C protein expression was up-regulated, their mRNA levels were decreased in donor versus control lung biopsies (P<0.05). VEGF-B mRNA was decreased, but its protein level was unchanged in donors. Flt-1 was unchanged, KDR gene expression was down-regulated in donors (P<0.05), and both receptors' protein expression was under the detection level in donor and control lungs. VEGF-A was detected in pulmonary vessels and bronchi, whereas VEGF-C was only detectable in vessels of both donor and control lungs. After transplantation, serum VEGF increased (P<0.05) and returned to control baseline levels 12 weeks after surgery. Wet-to-dry lung weight was increased in donor versus control lungs.
CONCLUSIONS: These results indicate that unventilated hypoxia increases vascular permeability in lung grafts and that this process is mainly regulated at VEGF-A and VEGF-C translational but not transcriptional level. Selective VEGF antagonism during graft preservation might be of benefit to counteract edema formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084990     DOI: 10.1097/00007890-200206150-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  21 in total

1.  Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury.

Authors:  Sei-ichiro Tsuchihashi; Bibo Ke; Fady Kaldas; Evelyn Flynn; Ronald W Busuttil; David M Briscoe; Jerzy W Kupiec-Weglinski
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 2.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

3.  VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.

Authors:  Fan Zhang; Zhongshu Tang; Xu Hou; Johan Lennartsson; Yang Li; Alexander W Koch; Pierre Scotney; Chunsik Lee; Pachiappan Arjunan; Lijin Dong; Anil Kumar; Tuomas T Rissanen; Bin Wang; Nobuo Nagai; Pierre Fons; Robert Fariss; Yongqing Zhang; Eric Wawrousek; Ginger Tansey; James Raber; Guo-Hua Fong; Hao Ding; David A Greenberg; Kevin G Becker; Jean-Marc Herbert; Andrew Nash; Seppo Yla-Herttuala; Yihai Cao; Ryan J Watts; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

4.  Association of aorta intima permeability with myosin light chain kinase expression in hypercholesterolemic rabbits.

Authors:  Hua-Qing Zhu; Qing Zhou; Zhi-Kui Jiang; Shu-Yu Gui; Yuan Wang
Journal:  Mol Cell Biochem       Date:  2010-10-30       Impact factor: 3.396

5.  The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.

Authors:  Ksenya Shchors; Elena Shchors; Fanya Rostker; Elizabeth R Lawlor; Lamorna Brown-Swigart; Gerard I Evan
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

Review 6.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

7.  VEGF expression in patellar tendinopathy: a preliminary study.

Authors:  Alexander Scott; Øystein Lian; Roald Bahr; David A Hart; Vincent Duronio
Journal:  Clin Orthop Relat Res       Date:  2008-05-06       Impact factor: 4.176

Review 8.  Vascular endothelial growth factors in pulmonary edema: an update.

Authors:  Ioanna Kosmidou; Dimitrios Karmpaliotis; Ajay J Kirtane; Hal V Barron; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2007-06-07       Impact factor: 2.300

Review 9.  VEGF-B: a survival, or an angiogenic factor?

Authors:  Xuri Li; Chunsik Lee; Zhongshu Tang; Fan Zhang; Pachiappan Arjunan; Yang Li; Xu Hou; Anil Kumar; Lijin Dong
Journal:  Cell Adh Migr       Date:  2009-10-03       Impact factor: 3.405

Review 10.  Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.

Authors:  Mary K Porteous; Joshua M Diamond; Jason D Christie
Journal:  Curr Opin Organ Transplant       Date:  2015-10       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.